If you read the announcement released on 28th March 2023 it says this:
So if that person went from Cohort 1 to Cohort 2, that means that there were five patients remaining in Cohort 1.
Did the Company then find another patient to move into Cohort 1? And did the Company only have to recruit five patients to fill the required six for Cohort 2?
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1269
-
- There are more pages in this discussion • 156 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.015(7.32%) |
Mkt cap ! $95.68M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 23.0¢ | 21.5¢ | $428.7K | 1.987M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 69000 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 67859 | 2 |
View Market Depth
| Last trade - 15.56pm 15/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |